Palkion's Series C Round

Palkion raised a round of funding on August 14, 2009.

Palkion, Inc. is a private early stage company developing oral drugs to treat anemia based on the discovery and development of compounds that inhibit prolyl hydroxylase enzymes.…

Articles about Palkion's Series C Round: